Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy
1997

Improving Survival in Endometrial Cancer with Node Metastases

Sample size: 173 publication Evidence: moderate

Author Information

Author(s): T Onda, H Yoshikawa, K Mizutani, M Mishima, H Yokota, H Nagano, Y Ozaki, A Murakami, K Ueda, Y Taketani

Primary Institution: University of Tokyo

Hypothesis

Does systematic aortic and pelvic lymphadenectomy followed by adjuvant therapy improve survival in node-positive endometrial cancer patients?

Conclusion

Aortic and pelvic lymphadenectomy followed by chemotherapy and radiation therapy based on node status improves survival in endometrial cancer patients with positive nodes.

Supporting Evidence

  • Five-year survival was 95% for patients with negative nodes and 84% for those with positive nodes.
  • Patients with pelvic node metastases alone had a 100% five-year survival rate.
  • Patients with aortic node metastases had a 75% five-year survival rate.

Takeaway

Doctors found that removing lymph nodes and giving treatment helps women with a certain type of cancer live longer.

Methodology

Patients underwent systematic aortic and pelvic lymphadenectomy followed by chemotherapy and radiation therapy based on node status.

Limitations

The study may not represent all endometrial cancer patients as it focused on those with node-positive disease.

Participant Demographics

Mean age of participants was 55.8 years, with a range from 30 to 77 years.

Statistical Information

P-Value

0.30

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication